Tag: Merck

Merck announces over €300m investment in new bioprocessing center in South Korea

businessnewstoday- March 21, 2024

Merck has embarked on a monumental investment venture, injecting more than €300 million into the construction of a new Bioprocessing Production Center located in Daejeon, ... Read More

Merck’s KEYTRUDA shows 38% reduction in death risk for renal cell carcinoma patients in Phase 3 KEYNOTE-564 trial

businessnewstoday- January 29, 2024

Merck & Co., Inc., a global healthcare leader, has recently unveiled groundbreaking results from its Phase 3 KEYNOTE-564 trial. This pivotal study demonstrates that KEYTRUDA, ... Read More

FDA approves Merck’s KEYTRUDA for advanced cervical cancer treatment

businessnewstoday- January 14, 2024

Merck, known as MSD outside of the United States and Canada, has received approval from the U.S. Food and Drug Administration (FDA) for KEYTRUDA, its ... Read More

Merck to acquire Harpoon Therapeutics for $680m to strengthen oncology pipeline

businessnewstoday- January 9, 2024

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Harpoon Therapeutics, Inc. (Nasdaq: HARP) have entered a definitive agreement where Merck ... Read More

Merck, Inspirna join forces to develop first-in-class oral cancer inhibitor

businessnewstoday- January 6, 2024

Merck, a renowned science and technology company, has reached a significant milestone in its efforts to combat cancer. The company announced a strategic licensing agreement ... Read More

Moderna, Merck announce promising results for mRNA-4157 and Keytruda in melanoma

businessnewstoday- December 15, 2023

Moderna, Inc. (NASDAQ: MRNA) and Merck (NYSE: MRK), also known as MSD outside the United States and Canada, today revealed follow-up data from their collaborative ... Read More

Merck to acquire Caraway Therapeutics in $610m deal for neurodegenerative disease treatments

businessnewstoday- November 22, 2023

Merck and Caraway Therapeutics, Inc. have announced a definitive agreement in which Merck, through a subsidiary, will acquire Caraway Therapeutics. The total potential consideration for ... Read More

Merck strikes €1.4bn deal with Hengrui Pharmaceuticals for next-gen oncology treatments

businessnewstoday- October 31, 2023

In a major advancement in cancer treatment, Merck, a frontrunner in science and technology, has declared a strategic collaboration with Jiangsu Hengrui Pharmaceuticals Co. Ltd. ... Read More

Merck launches Phase 3 CORALreef program for PCSK9 inhibitor MK-0616

businessnewstoday- August 25, 2023

Pharmaceutical giant Merck has announced the initiation of its groundbreaking Phase 3 clinical program, CORALreef, focusing on MK-0616—a novel, oral proprotein convertase subtilisin/kexin type 9 ... Read More

Merck’s WELIREG meets primary endpoint of PFS in Phase 3 RCC trial

businessnewstoday- August 20, 2023

Global pharmaceutical leader Merck has announced that WELIREG (belzutifan), its pioneering oral HIF-2α inhibitor, has achieved a critical milestone in its Phase 3 trial LITESPARK-005. ... Read More